NCT02305693 Comparison Between Letrozole and Laparoscopic Ovarian Drilling in Women With Clomiphene Resistant Polycystic Ovarian Syndrome (PCOS) Status UNKNOWN Phase PHASE3
NCT02304107 Comparison Between Letrozole and Urinary Purified FSH in Women With Clomiphene Citrate Resistant Polycystic Ovarian Syndrome. Status COMPLETED Phase PHASE3
NCT02297438 A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] Status COMPLETED Phase PHASE3
NCT02296801 A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer Status COMPLETED Phase PHASE2
NCT02294773 Study Evaluating the Timing of Intrauterine Insemination in Relation to Positive Home Ovulation Prediction Kit Status COMPLETED Phase NA
NCT02291913 Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT02283658 Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer Status COMPLETED Phase PHASE2
NCT02278120 Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Status COMPLETED Phase PHASE3
NCT02273973 A Study of Neoadjuvant Letrozole + Taselisib Versus Letrozole + Placebo in Post-Menopausal Women With Breast Cancer (LORELEI) Status COMPLETED Phase PHASE2
NCT02246621 A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02228681 Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer Status COMPLETED Phase PHASE2
NCT02221999 Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02214004 Neoadjuvant Trastuzumab and Letrozole for Postmenopausal Women Status UNKNOWN Phase PHASE2
NCT02158689 Comparison of Treatment Modalities in Poor Responders Undergoing IVF Status COMPLETED Phase NA
NCT02154776 Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. Status COMPLETED Phase PHASE1
NCT02152943 Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients Status COMPLETED Phase PHASE1
NCT02142868 Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate Status NO_LONGER_AVAILABLE Phase N/A
NCT02137538 Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole Status COMPLETED Phase PHASE4